Search

Your search keyword '"Ursula, Amstutz"' showing total 27 results

Search Constraints

Start Over You searched for: Author "Ursula, Amstutz" Remove constraint Author: "Ursula, Amstutz" Topic 03 medical and health sciences Remove constraint Topic: 03 medical and health sciences
27 results on '"Ursula, Amstutz"'

Search Results

1. Haplotype structure defines effects of common DPYD variants c.85T > C (rs1801265) and c.496A > G (rs2297595) on dihydropyrimidine dehydrogenase activity: Implication for 5-fluorouracil toxicity

2. CYP2D6 as a treatment decision aid for ER-positive non-metastatic breast cancer patients: a systematic review with accompanying clinical practice guidelines

3. Come a long way, still a ways to go: from predicting and preventing fluoropyrimidine toxicity to increased efficacy?

4. Clinical value of molecular MRD monitoring by next-generation sequencing in patients with IDH2 mutated AML

5. Metamizole-associated neutropenia: Comparison of patients with neutropenia and metamizole-tolerant patients

6. 4th ESPT summer school: precision medicine and personalised health

7. Recommendations for genetic testing to reduce the incidence of anthracycline‐induced cardiotoxicity

8. The impact of ABCC11 polymorphisms on the risk of early-onset fluoropyrimidine toxicity

9. Rs895819 inMIR27Aimproves the predictive value ofDPYDvariants to identify patients at risk of severe fluoropyrimidine-associated toxicity

10. Pharmacogenomic screening for anthracycline‐induced cardiotoxicity in childhood cancer

11. Evaluating the role of ENOSF1 and TYMS variants as predictors in fluoropyrimidine-related toxicities: An IPD meta-analysis

12. Dihydropyrimidinase and beta-ureidopropionase gene variation and severe fluoropyrimidine-related toxicity

13. Assessment of hair cortisol as a potential biomarker for possible adrenal suppression due to inhaled corticosteroid use in children with asthma: A retrospective observational study

14. Association Between SLC16A5 Genetic Variation and Cisplatin-Induced Ototoxic Effects in Adult Patients With Testicular Cancer

15. Genotype-guided fluoropyrimidine dosing: ready for implementation

16. HLA-A*31:01 and HLA-B*15:02 as Genetic Markers for Carbamazepine Hypersensitivity in Children

17. Novel Genetic Variants in Carboxylesterase 1 Predict Severe Early-Onset Capecitabine-Related Toxicity

18. Hair cortisol as a hypothalamic-pituitary-adrenal axis biomarker in pregnant women with asthma: a retrospective observational study

19. LC-MS/MS method for simultaneous analysis of uracil, 5,6-dihydrouracil, 5-fluorouracil and 5-fluoro-5,6-dihydrouracil in human plasma for therapeutic drug monitoring and toxicity prediction in cancer patients

20. Sequence capture and next-generation resequencing of multiple tagged nucleic acid samples for mutation screening of urea cycle disorders

21. Dihydropyrimidine dehydrogenase gene as a major predictor of severe 5-fluorouracil toxicity

22. Dihydropyrimidine dehydrogenase gene variation and severe 5-fluorouracil toxicity: a haplotype assessment

23. Clinical importance of risk variants in the dihydropyrimidine dehydrogenase gene for the prediction of early-onset fluoropyrimidine toxicity

24. Practical recommendations for pharmacogenomics-based prescription: 2010 ESF-UB Conference on Pharmacogenetics and Pharmacogenomics

25. Hypermethylation of the DPYD promoter region is not a major predictor of severe toxicity in 5-fluorouracil based chemotherapy

26. Population transcriptomics of life-history variation in the genus Salmo

27. The genetic basis of smoltification : functional genomics tools faciltate the search for the needle in the haystack

Catalog

Books, media, physical & digital resources